DK3057934T3 - Halogenerede estere af cyklopropanerede umættede fedtsyrer til anvendelse ved behandling af neurodegenerative sygdomme - Google Patents

Halogenerede estere af cyklopropanerede umættede fedtsyrer til anvendelse ved behandling af neurodegenerative sygdomme Download PDF

Info

Publication number
DK3057934T3
DK3057934T3 DK14793391.5T DK14793391T DK3057934T3 DK 3057934 T3 DK3057934 T3 DK 3057934T3 DK 14793391 T DK14793391 T DK 14793391T DK 3057934 T3 DK3057934 T3 DK 3057934T3
Authority
DK
Denmark
Prior art keywords
cyclopropanated
treatment
fatty acids
unsaturated fatty
neurodegenerative diseases
Prior art date
Application number
DK14793391.5T
Other languages
English (en)
Inventor
Thomas J Nelson
Daniel L Alkon
Original Assignee
Blanchette Rockefeller Neurosciences Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blanchette Rockefeller Neurosciences Inst filed Critical Blanchette Rockefeller Neurosciences Inst
Application granted granted Critical
Publication of DK3057934T3 publication Critical patent/DK3057934T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/336Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having three-membered rings, e.g. oxirane, fumagillin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/62Halogen-containing esters
    • C07C69/63Halogen-containing esters of saturated acids
    • C07C69/635Halogen-containing esters of saturated acids containing rings in the acid moiety
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00Systems containing two condensed rings
    • C07C2602/02Systems containing two condensed rings the rings having only two atoms in common

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK14793391.5T 2013-10-18 2014-10-20 Halogenerede estere af cyklopropanerede umættede fedtsyrer til anvendelse ved behandling af neurodegenerative sygdomme DK3057934T3 (da)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201361892727P 2013-10-18 2013-10-18
US201361896735P 2013-10-29 2013-10-29
US201461925441P 2014-01-09 2014-01-09
US201461925449P 2014-01-09 2014-01-09
PCT/US2014/061368 WO2015058191A1 (en) 2013-10-18 2014-10-20 Halogenated esters of cyclopropanated unsaturated fatty acids for use in the treatment of neurodegenerative diseases

Publications (1)

Publication Number Publication Date
DK3057934T3 true DK3057934T3 (da) 2019-07-01

Family

ID=51846995

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14793391.5T DK3057934T3 (da) 2013-10-18 2014-10-20 Halogenerede estere af cyklopropanerede umættede fedtsyrer til anvendelse ved behandling af neurodegenerative sygdomme

Country Status (9)

Country Link
US (4) US9962357B2 (da)
EP (3) EP4101835A1 (da)
JP (1) JP2016535012A (da)
CA (1) CA2927675A1 (da)
DK (1) DK3057934T3 (da)
ES (2) ES2732153T3 (da)
PL (1) PL3057934T3 (da)
PT (1) PT3057934T (da)
WO (1) WO2015058191A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017062924A1 (en) * 2015-10-08 2017-04-13 Alkon Daniel L Dosing regimens of pkc activators

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY118354A (en) * 1995-05-01 2004-10-30 Scarista Ltd 1,3-propane diol derivatives as bioactive compounds
JPH10139735A (ja) * 1996-09-13 1998-05-26 Sumitomo Chem Co Ltd エステル化合物、それを有効成分とする有害生物防除剤およびその製造中間体
AU2001235363A1 (en) * 2000-02-25 2001-09-03 Novo-Nordisk A/S Mibefradil analogues and their use
CN101284136A (zh) 2002-12-03 2008-10-15 布朗歇特洛克菲勒神经科学研究所 传输物质穿过血脑屏障的人工低密度脂蛋白载体
US7521447B2 (en) * 2003-03-03 2009-04-21 Array Biopharma Inc. P38 inhibitors and methods of use thereof
DE10351087A1 (de) * 2003-10-31 2005-05-25 Bayer Technology Services Gmbh Feste Wirkstoff-Formulierung
CN101223884B (zh) 2007-01-15 2011-07-13 大日本除虫菊株式会社 杀虫防虫剂或害虫的摄食阻碍剂
US8163800B2 (en) 2008-07-28 2012-04-24 Blanchette Rockefeller Neurosciences Institute PKC-activating compounds for the treatment of neurodegenerative diseases
CN101608402B (zh) 2009-07-14 2011-07-27 东华大学 植物油改性含氟拒水整理剂、制备方法及其应用
AU2010313249B2 (en) 2009-10-30 2016-05-19 Biojiva Llc Alleviating oxidative stress disorders with PUFA derivatives
CN109608436B (zh) * 2011-04-08 2022-10-11 斯法尔制药私人有限公司 取代的甲基甲酰基试剂及使用所述试剂改进化合物物理化学和/或药代动力学性质的方法
WO2012148891A1 (en) * 2011-04-29 2012-11-01 Evonik Degussa Corporation Peptide-lipid conjugates and uses thereof
WO2013071281A1 (en) 2011-11-13 2013-05-16 Blanchette Rockefeller Neurosciences Institute Esters of dcpla and methods of treatment using the same

Also Published As

Publication number Publication date
CA2927675A1 (en) 2015-04-23
US20220151973A1 (en) 2022-05-19
US11273139B2 (en) 2022-03-15
ES2732153T3 (es) 2019-11-20
US20190192471A1 (en) 2019-06-27
EP3567025B8 (en) 2023-01-25
US12016837B2 (en) 2024-06-25
EP3567025B1 (en) 2022-08-03
EP4101835A1 (en) 2022-12-14
ES2927760T3 (es) 2022-11-10
WO2015058191A1 (en) 2015-04-23
EP3057934B1 (en) 2019-03-27
PL3057934T3 (pl) 2019-09-30
US20180325856A1 (en) 2018-11-15
PT3057934T (pt) 2019-06-28
US9962357B2 (en) 2018-05-08
EP3567025A1 (en) 2019-11-13
JP2016535012A (ja) 2016-11-10
US20160256427A1 (en) 2016-09-08
EP3057934A1 (en) 2016-08-24
ES2927760T8 (es) 2023-05-05

Similar Documents

Publication Publication Date Title
HK1218078A1 (zh) 非酒精性脂肪性肝病治療劑
DK2919796T3 (da) Brug af akkermansia til behandling af stofskiftesygdomme
HK1225964A1 (zh) 用hdac6抑制劑治療多囊性疾病
CO6910186A2 (es) Uso de ácidos grasos omega para el tratamiento de enfermedades
EP2809317A4 (en) FATTY ACIDS AS ANTI-INFLAMMATORY AGENTS
EP2941252A4 (en) USE OF FATTY ACID NIACIN CONJUGATES FOR THE TREATMENT OF DISEASES
PT2964215T (pt) Mistura de ácidos gordos para utilização no tratamento de patologias inflamatórias
EP3177587A4 (en) Fragrances from the esters of fatty acids
DK3149049T3 (da) Il-22 til anvendelse til behandling af stofskiftesygdomme
HK1216614A1 (zh) 治療脂肪肝疾病的方法
HK1221190A1 (zh) 炎症性眼科疾病的局部治療
DK3305755T3 (da) Ny fremgangsmåde til at fremstille stærkt umættede fedtsyreestere
IL245199A0 (en) Processes for the preparation of unsaturated esters
ZA201603117B (en) Withanolides useful for the treatment of neurodegenerative diseases
SG11201600700UA (en) Preparation of methyl methacrylate via an oxidative esterification process
DK3024816T3 (da) Ppar-sparende forbindelser til behandling af metaboliske sygdomme
DK3057934T3 (da) Halogenerede estere af cyklopropanerede umættede fedtsyrer til anvendelse ved behandling af neurodegenerative sygdomme
IL241934A (en) Inhibitory peptides for the treatment of inflammatory diseases
TH1601000171A (th) องค์ประกอบที่อีมัลซิฟายได้เองของ Omega3 แฟตตี้แอซิด
SG11201608898UA (en) Unsaturated fatty acid absorption accelerator
TH1301005844B (th) กระบวนการสำหรับเอสเทอริฟิเคชันแบบเร่งปฏิกิริยาได้เองของกรดไขมัน
TH1601003079A (th) การกำจัดกรดไขมันอิสระจากน้ำมันกลีเซอไรด์
TH1401007907A (th) ไลเปสในกระบวนการเอสเตอริฟิเคชันของแฟตตี้แอซิดแบบสายสั้น
TH1501001178A (th) วิธีการสำหรับการผลิตกรดชนิดไม่อิ่มตัว และ/หรือ เอสเทอร์ของกรดชนิดไม่อิ่มตัว
TH1601002735A (th) ไขมันที่มีพอลิอันแซทูเรเทด แฟททิ แอซิด